Rate-Adaptive AV Timing with P-Wave Truncation Prevention

The patent extracts the essential function of AV interval optimization from complex echocardiographic methods and implements it directly within the pacemaker device using intracardiac signals. By taking out the core optimization capability and embedding it in the implantable device, the system eliminates the need for external echocardiographic equipment and complex external optimization procedures, thereby reducing device complexity and clinical time requirements while maintaining optimization accuracy.

The system applies self-service by enabling the pacemaker to automatically optimize its own AV intervals using intracardiac electrograms and ECG signals that are already being acquired for other pacing functions. The device performs self-diagnosis and self-adjustment of AV timing without requiring external echocardiographic guidance, thereby simplifying the overall system while maintaining precise optimization capability.

The patent applies dynamics by implementing rate-adaptive AV timing that automatically adjusts the AV interval based on detected heart rate changes. The system continuously monitors heart rate and dynamically modifies the AV delay to optimize ventricular filling at each heart rate level, thereby improving adaptability across varying physiological conditions while maintaining safe filling patterns.

The system combines preliminary anti-action with dynamics by establishing a minimum AV interval threshold that cannot be exceeded even during rate adaptation. This predetermined safety bound prevents the adaptive mechanism from producing harmful effects, ensuring that while the AV interval dynamically adjusts to heart rate changes, it never shortens to a level that would compromise ventricular filling.